...
首页> 外文期刊>British Journal of Dermatology >Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
【24h】

Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.

机译:女性脱发:增加头皮头发丰满度的医学和美容方法。

获取原文
获取原文并翻译 | 示例
           

摘要

Androgenetic alopecia affects both men and women. In men it produces male pattern hair loss with bitemporal recession and vertex baldness. In women it produces female pattern hair loss (FPHL) with diffuse alopecia over the mid-frontal scalp. FPHL occurs as a result of nonuniform hair follicle miniaturization within follicular units. Diffuse alopecia is produced by a reduction in the number of terminal fibres per follicular unit. Baldness occurs only when all hairs within the follicular units are miniaturized and is a relatively late event in women. The concepts of follicular units and primary and secondary hair follicles within follicular units are well established in comparative mammalian studies, particularly in sheep. However, discovery of these structures in the human scalp hair and investigation of the changes in follicular unit anatomy during the development of androgenetic alopecia have provided a clearer understanding of the early stages of androgenetic alopecia and how the male and female patterns of hair loss are related. FPHL is the most common cause of alopecia in women and approximately one-third of adult caucasian women experience hair loss. The impact of FPHL is predominantly psychological. While men anticipate age-related hair loss, hair loss in women is usually unexpected and unwelcome at any age. Treatment options to arrest hair loss progression and stimulate partial hair regrowth for FPHL include the androgen receptor antagonists spironolactone and cyproterone acetate, the 5alpha-reductase inhibitor finasteride and the androgen-independent hair growth stimulator minoxidil. These treatments appear to work best when initiated early. Hair transplantation should be considered in advanced FPHL that is resistant to medical treatments. Hair transplantation requires well-preserved hair growth over the occipital donor area. The psychological impact of FPHL may also be reduced by cosmetic products that improve the appearance of the hair. These agents work to minimize hair fibre breakage, improve hair volume or conceal visible bald scalp.
机译:雄激素性脱发会影响男性和女性。在男性中,它会产生男性型脱发,伴有暂时性衰退和顶点秃发。在女性中,它会产生女性型脱发(FPHL),中额头皮上的弥漫性脱发。 FPHL的出现是由于毛囊单位内毛囊微型化不均匀所致。弥漫性脱发是由于每个卵泡单位的末端纤维数量减少而产生的。仅当卵泡单位内的所有头发都缩小时才发生秃发,并且在女性中是相对较晚的事件。卵泡单位以及卵泡单位内的初级和次级毛囊的概念在比较的哺乳动物研究中,尤其是在绵羊中已经得到了很好的确立。然而,在人类头皮头发中发现这些结构并研究雄激素性脱发过程中滤泡单元解剖结构的变化,使人们对雄激素性脱发的早期阶段以及脱发的男性和女性模式之间的关系有了更清晰的了解。 。 FPHL是女性脱发的最常见原因,大约三分之一的成年白人女性会脱发。 FPHL的影响主要是心理上的。虽然男性预期与年龄有关的脱发,但女性脱发通常在任何年龄都是意外的和不受欢迎的。阻止脱发进程并刺激部分FPHL的头发再生的治疗选择包括雄激素受体拮抗剂螺内酯和醋酸环丙孕酮,5α-还原酶抑制剂非那雄胺和非雄激素非依赖性的毛发生长刺激剂Minoxidil。这些治疗在早期开始时似乎效果最好。晚期FPHL应考虑对医疗的抵抗力,以进行毛发移植。头发移植需要在枕骨供体区域上保存完好的头发生长。 FPHL的心理影响还可以通过改善头发外观的化妆品来减轻。这些制剂可最大程度地减少头发纤维断裂,改善头发体积或隐藏可见的秃头皮。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号